Radiology

Radiation and Your Patient Survivorship care plans: The shift back to primary care

Survivorship care plans: The shift back to primary care

New templates from the American Society of Clinical Oncology (ASCO) will augment successful cancer survivorship care planning. But a stronger effort toward implementation is still needed.

ASCO 2015 Annual Meeting Radiosurgery and Careful Monitoring Combo Recommended for Newly Diagnosed Brain Metastases

Radiosurgery and Careful Monitoring Combo Recommended for Newly Diagnosed Brain Metastases

Radiosurgery and close monitoring is recommended to better preserve cognitive function in newly diagnosed brain metastases.

ASCO 2015 Annual Meeting Combination of mFOLFOX6 and Radiotherapy Yields Higher pCR in Rectal Cancer

Combination of mFOLFOX6 and Radiotherapy Yields Higher pCR in Rectal Cancer

mFOLFOX6 administered concurrently with radiation therapy resulted in a higher pathological complete response in rectal cancer.

ASCO 2015 Annual Meeting Optimal Sequencing for Chemotherapy and Radium 223 for Prostate Cancer Under Debate

Optimal Sequencing for Chemotherapy and Radium 223 for Prostate Cancer Under Debate

When is chemotherapy or radium 223 the optimal treatment for men with advanced prostate cancer?

Radiation and Your Patient Identifying biomarkers for radiation pneumonitis

Identifying biomarkers for radiation pneumonitis

Interstitial lung disease appears to be a risk factor for radiation pneumonitis, a potentially life-threatening adverse effect of radiotherapy to the chest and thorax.

Publishers Alliance Minimizing second cancer risk following radiotherapy: current perspectives

Minimizing second cancer risk following radiotherapy: current perspectives

[Cancer Management and Research] Secondary cancer risk following radiotherapy is an increasingly important topic in clinical oncology with impact on treatment decision making and on patient management.

Radiation and Your Patient Using genomic correlates of radiotoxicity to predict patient outcomes

Using genomic correlates of radiotoxicity to predict patient outcomes

Radiogenomics is maturing into a predictor of patients' likelihood of experiencing radiotoxicities and late radiation effects.

Radiation and Your Patient Monitoring psychosocial function in radiotherapy

Monitoring psychosocial function in radiotherapy

Psychosocial decline occurs in an estimated one-third of patients undergoing radiotherapy for cancer. These declines may sometimes be ameliorated by vigilant recognition of the need to refer patients for psychosocial support interventions.

Radiation and Your Patient High-dose rate brachytherapy: From adjuvant therapy to an alternative for prostate cancer

High-dose rate brachytherapy: From adjuvant therapy to an alternative for prostate cancer

High-dose-rate (HDR) brachytherapy is typically used as a dose-escalating boost for external beam radiotherapy for prostate cancer; however, some researchers believe it might be close to graduating to a viable monotherapy.

Radiation and Your Patient A review of radiotherapy-induced hypopituitarism

A review of radiotherapy-induced hypopituitarism

Some patients undergoing radiotherapy for cancers of the head, neck, and brain are at risk for endocrinopathies. This article reviews the risks, detection, and management of radiotherapy-induced hypopituitarism.

Partial versus entire breast radiation does not increase recurrence

Partial versus entire breast radiation does not increase recurrence

Women diagnosed with breast cancer and treated with a one-week regimen of partial breast radiation after tumor removal saw no increase in cancer recurrence or difference in cosmetic outcomes.

Multimodality treatment for metastatic lung cancer with surgery may improve survival

Patients with an advanced form of metastatic non-small cell lung cancer (NSCLC) may benefit from surgical resection of all or part of the lung if combined with chemotherapy and radiation therapy.

Discovery could improve effectiveness of radiotherapy in a wide range of cancers

Administering AKT inhibitors in combination with radiotherapy could bolster its effectiveness across a wide range of cancers, according to a study.

Large increase in pediatric patients treated with proton therapy

A new nationwide survey has indicated that the number of pediatric cancer patients being treated with proton radiation therapy is on the rise.

Proton therapy for esophageal cancer has fewer side effects than older radiation therapies

New research indicates that treating patients with esophageal cancer with proton therapy produces fewer toxic side effects than utilizing older radiation therapies.

Stereotactic ablative radiotherapy (SABR) offers better overall survival than surgery in early lung cancer

Stereotactic ablative radiotherapy (SABR) offers better overall survival than surgery in early lung cancer

Patients with operable stage I non-small cell lung cancer can achieve better overall survival rates if treated with stereotactic ablative radiotherapy (SABR) opposed to the current standard therapy.

Certain treatments for childhood cancer may increase obesity risk later in life

Cancer treatments in early life can lead to obesity in later years, and counseling and weight loss interventions for certain childhood cancer survivors are important.

Patients older than 60 years on hormone therapy for luminal A breast cancer may not need radiation

Women with luminal A subtype breast cancer, especially those older than 60 years, may not need radiation treatment if they are already taking hormone therapy.

Treatment factors examined that are associated with improved survival in oral cavity cancer

Neck dissection of lymph nodes and treatment at academic or research institutions are both associated with improved survival for patients with stages I and II oral cavity squamous cell cancer, according to recent research.

Moderate exercise may make cancer treatments more effective

Moderate exercise on a regular basis enhances tumor oxygenation, which may in turn improve treatment efficacy for cancer patients.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs